Pace mapping stands as a pivotal method within the realm of electrophysiology, utilized to investigate and pinpoint the origins of abnormal heart rhythms, commonly known as arrhythmias. In this diagnostic procedure, a comprehensive map of the heart's electrical activity is meticulously crafted by pacing the heart at various points. This involves the systematic stimulation of diverse regions of the heart to analyze responses, enabling healthcare professionals to identify potential sites responsible for arrhythmias. With its ability to guide ablation procedures, pace mapping aids electrophysiologists in precisely targeting and eliminating abnormal tissue, which is the root cause of irregular heartbeats. The precision offered by this technique significantly enhances the success rates of ablation procedures, ultimately contributing to a more effective and tailored approach to managing cardiac arrhythmias.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States